Starting a cannabis extraction operation is a complex process that requires a comprehensive understanding of regulations. But how can a new company comply with all these requirements? Michael Leavitt of Root Engineers explains.
A look to the next four years of cannabis policies under Joe Biden.
Inductively coupled plasma mass spectrometry (ICP-MS) is a flexible chemical analysis method that can be tailored to meet the demands of a wide variety of industries. In this article, we explore how it works, what it tells us, it's strengths and limitations and how it compares to other techniques in this analytical space.
Psilocybin’s emergence as a valuable tool for mental health research has been a huge breakthrough for the field. But how do researchers get their hands on this heavily regulated substance? We talked to Tim Moore, CEO of Havn Life Sciences, a company that produces psychoactive compounds from plants and fungi, to find out more.
Several American states voted to legalize cannabis this November 2020. Will they succeed?
The role that psychedelic therapeutics could play in tackling many intractable mental health conditions has finally been recognized by mainstream medicine. To find out more, we spoke to Carol Routledge, chief medical and scientific officer at Small Pharma.
With the cannabis industry’s increasing acceptance and regulation, mass spectrometry has also become a technique near-indispensable to the analytical scientists working within the cannabis testing sector.
This three-part series will take a closer look at the real-world, practical assessment of Colorado’s intent to implement these new regulations and their implications for other states that will inevitably follow suit.